Anja Lautem

512 total citations
18 papers, 376 citations indexed

About

Anja Lautem is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Anja Lautem has authored 18 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Anja Lautem's work include Drug Transport and Resistance Mechanisms (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Liver Disease and Transplantation (4 papers). Anja Lautem is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Liver Disease and Transplantation (4 papers). Anja Lautem collaborates with scholars based in Germany, United States and Australia. Anja Lautem's co-authors include Maria Hoppe‐Lotichius, Peter R. Galle, Tim Zimmermann, Michael Heise, Jörn M. Schattenberg, Nina Weiler, Arno Schad, Daniel Foltys, Anca Zimmermann and Marcus Schuchmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Anja Lautem

17 papers receiving 374 citations

Peers

Anja Lautem

ONCOL

SURGE

HEPAT

U Grützner Germany

Valeria Sanna Italy

Hidesuke Yanagida Japan

Maria Piera Panozzo Italy

Daniel Foltys Germany

Álvaro Santos‐Laso Spain

Yue Tao China

Ekaphop Sirachainan Thailand

Takafumi Tamura Japan

U Grützner Germany

Anja Lautem

183 ×1.0

ONCOL

94 ×0.6

SURGE

53 ×0.6

59 ×0.8

HEPAT

15 ×0.2

Citations per year, relative to Anja Lautem Anja Lautem (= 1×) peers U Grützner

Countries citing papers authored by Anja Lautem

Since Specialization

Citations

This map shows the geographic impact of Anja Lautem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Lautem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Lautem more than expected).

Fields of papers citing papers by Anja Lautem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Lautem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Lautem. The network helps show where Anja Lautem may publish in the future.

Co-authorship network of co-authors of Anja Lautem

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Lautem. A scholar is included among the top collaborators of Anja Lautem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Lautem. Anja Lautem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lautem, Anja, Simone Cosima Boedecker-Lips, Stefan Runkel, et al.. (2023). The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients. Pathogens. 12(7). 910–910.

Boedecker-Lips, Simone Cosima, Anja Lautem, Stefan Runkel, et al.. (2022). Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients. Pathogens. 11(1). 67–67. 11 indexed citations

Häuser, Friederike, Jens Mittler, A. Zimmermann, et al.. (2020). Hepatitis E Is a Rare Finding in Liver Transplant Patients With Chronic Elevated Liver Enzymes and Biopsy-Proven Acute Rejection. Transplantation Proceedings. 52(3). 926–931. 6 indexed citations

Lautem, Anja, Frank A. Simon, Maria Hoppe‐Lotichius, et al.. (2019). Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization. Oncology Reports. 41(4). 2299–2310. 5 indexed citations

Zimmermann, Anca, Maria Hoppe‐Lotichius, Gerrit Toenges, et al.. (2019). Cirrhosis Risk Score of the Donor Organ Predicts Early Fibrosis Progression after Liver Transplantation. Journal of Gastrointestinal and Liver Diseases. 28(1). 53–61. 5 indexed citations

Zimmermann, Anca, Maria Hoppe‐Lotichius, Gerrit Toenges, et al.. (2019). Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation. Journal of Gastrointestinal and Liver Diseases. 28(1). 53–61. 4 indexed citations

Nepal, Chirag, Colm J. O’Rourke, Douglas V.N.P. Oliveira, et al.. (2017). Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. Hepatology. 68(3). 949–963. 92 indexed citations

Lautem, Anja, Ellen I. Closs, Detlef Schuppan, et al.. (2017). Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis. Oncotarget. 8(70). 115667–115680. 14 indexed citations

Grimm, Daniela, Veronika Weyer, Anja Lautem, et al.. (2016). Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment. BMC Cancer. 16(1). 94–94. 33 indexed citations

10.

Fuchs, Peter, Daniel Ghercă, Jens U. Marquardt, et al.. (2015). Relevance of organic cation transporter OCT1 (SLC22A1) in Diethylnitrosamine-initiated and Phenobarbital-promoted hepatocellular carcinoma in OCT3- knockout mice. Zeitschrift für Gastroenterologie. 53(1). 1 indexed citations

11.

Lautem, Anja, Michael Heise, Maria Hoppe‐Lotichius, et al.. (2013). Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma. International Journal of Oncology. 42(4). 1297–1304. 40 indexed citations

12.

Heise, Michael, Anja Lautem, Jörn M. Schattenberg, et al.. (2012). Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance. BMC Cancer. 12(1). 109–109. 87 indexed citations

13.

Heise, Michael, Anja Lautem, Jörn M. Schattenberg, et al.. (2012). 285 DOWNREGULATION OF ORGANIC CATION TRANSPORTERS OCT1 (SLC22A1) AND OCT3 (SLC22A3) IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR PROGNOSTIC SIGNIFICANCE. Journal of Hepatology. 56. S118–S118. 1 indexed citations

14.

Zimmermann, Tim, Maria Hoppe‐Lotichius, Andreas Körner, et al.. (2011). The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation. Transplant International. 24(11). 1059–1067. 3 indexed citations

15.

Foltys, Daniel, Thomas Zimmermann, Michael Heise, et al.. (2011). Liver Transplantation for Hepatocellular Carcinoma – Is There a Risk of Recurrence Caused by Intraoperative Blood Salvage Autotransfusion?. European Surgical Research. 47(3). 182–187. 36 indexed citations

16.

Zimmermann, Tim, Charles W. Otto, Maria Hoppe‐Lotichius, et al.. (2009). Risk Factors in Patients With Rapid Recurrent Hepatitis C Virus–Related Cirrhosis Within 1 Year After Liver Transplantation. Transplantation Proceedings. 41(6). 2549–2556. 12 indexed citations

17.

Heidenhain, Christoph, Gero Puhl, Christian Moench, Anja Lautem, & P. Neuhaus. (2009). Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation.. PubMed. 14(3). 36–44. 23 indexed citations

18.

Heidenhain, Christoph, Gero Puhl, Christian Moench, Anja Lautem, & P. Neuhaus. (2009). Chemokine Receptor-5Δ32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation. SHILAP Revista de lepidopterología. 2009. 1–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact